AtlasClear grants stock options to its CFO
AtlasClear Holdings, Inc. reported that its CFO and General Counsel, Sandip I. Patel, received two grants of stock options on July 14, 2026.
Rhea-AI Filing Summary
AtlasClear Holdings, Inc. reported that its CFO and General Counsel, Sandip I. Patel, received two grants of stock options on July 14, 2026. One grant covers 731,030 options to acquire common stock, and a second grant covers 45,000 options. Both option grants carry a $0.1800 exercise price per share, with expiration dates on June 30, 2031 and January 26, 2030, respectively. These awards are classified as grant or award acquisitions, not open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 776,030 shares
Grant/Award
2 txns
Insider
Patel Sandip I
Role
CFO and General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 45,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 731,030 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 776,030 contracts (Direct)
Key Figures
Options granted: 731,030 options
Second option grant: 45,000 options
Exercise price: $0.1800 per share
+2 more
5 metrics
Options granted
731,030 options
Stock option grant on 2026-07-14 to acquire common stock
Second option grant
45,000 options
Additional stock option grant on 2026-07-14 to acquire common stock
Exercise price
$0.1800 per share
Conversion or exercise price for both option grants
First grant expiration
2031-06-30
Expiration date of the 731,030-option award
Second grant expiration
2030-01-26
Expiration date of the 45,000-option award
Key Terms
Stock Option (right to buy), conversion or exercise price, derivative securities, expiration date
4 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
conversion or exercise price financial
"conversion_or_exercise_price: 0.1800"
derivative securities financial
"transaction_type: derivative"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
expiration date financial
"expiration_date: 2031-06-30"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did ATCH report for Sandip I. Patel?
AtlasClear Holdings (ATCH) reported that Sandip I. Patel received two stock option grants on July 14, 2026, covering 731,030 and 45,000 underlying common shares, respectively, both at an exercise price of $0.1800 per share.
How many stock options were granted to the ATCH CFO and General Counsel?
The CFO and General Counsel of ATCH, Sandip I. Patel, was granted 731,030 stock options in one award and 45,000 stock options in a second award, each relating to common stock and reported as derivative acquisitions.
What is the exercise price of Sandip Patel’s AtlasClear (ATCH) option grants?
Both of Sandip Patel’s option awards from AtlasClear (ATCH) have an exercise price of $0.1800 per share. Each grant is a stock option to buy common stock, with different expiration dates but the same stated conversion or exercise price.
When do the reported ATCH stock options held by Sandip Patel expire?
The reported AtlasClear (ATCH) stock option grants to Sandip Patel expire on June 30, 2031 for the 731,030-option award and January 26, 2030 for the 45,000-option award, according to the expiration dates disclosed for each derivative security.
AI-generated analysis. How Rhea-AI works. Not financial advice.
